Gaudium ivf & women health Limited has filed its quarterly compliance certificate with stock exchanges for the quarter ended March 31, 2026, in accordance with SEBI regulatory requirements. The company submitted the mandatory documentation under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Filing

The compliance certificate was submitted to both major Indian stock exchanges on April 10, 2026. Company Secretary and Compliance Officer Naveen Kumar, with membership number A69788, signed the filing on behalf of the company. The submission was made to BSE Limited and the National Stock Exchange of India Limited as part of the company's regular quarterly compliance obligations.

Registrar Confirmation

Bigshare Services Private Limited, serving as the company's registrar and transfer agent, issued a confirmation certificate dated April 9, 2026. The registrar confirmed that Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 is not applicable to Gaudium IVF and Women Health Limited for the quarter ended March 31, 2026.

Share Dematerialization Status

According to the registrar's certificate, the non-applicability of the regulation stems from the company's complete share dematerialization status. Key findings include:

• All company shares are held in dematerialized form
• No requests for rematerialization were received during the quarter
• No requests for dematerialization were received during the quarter
• The entire shareholding remains in electronic format

Corporate Information

The company, formerly known as Gaudium IVF and Women Health Private Limited, operates from its registered office at B1/51, Janak Puri, Janakpuri B-1, West Delhi, New Delhi. The filing represents part of the company's ongoing commitment to maintaining regulatory compliance with SEBI requirements for listed entities.

The submission of this compliance certificate demonstrates the company's adherence to depositories and participants regulations, ensuring transparency in share transfer and holding mechanisms for the quarter ended March 31, 2026.

Gaudium IVF & Women Health Limited has provided additional disclosures to stock exchanges regarding the arbitration proceedings filed against the company by Neomile Corporate Advisory Limited, following a query from BSE Limited seeking clarification on the ₹29,20,50,000 claim for alleged advisory services related to its Initial Public Offering.

BSE Query and Company Response

Following the company's initial disclosure on April 06, 2026, BSE Limited raised a query on April 07, 2026, seeking additional details in terms of SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company has now submitted the required comprehensive disclosures under Regulation 30 of SEBI Listing Regulations.

Court Proceedings Update

The Bombay High Court has disposed of the Commercial Arbitration Petition under Section 9 of the Arbitration and Conciliation Act, 1996, and appointed Hon'ble Mr. Justice Nitin Jamdar (Former Chief Justice, Kerala High Court) as the Sole Arbitrator to adjudicate upon the dispute. The court order was issued on April 02, 2026.

Disclosure Timeline Explanation

The company has provided a detailed explanation for the timing of its disclosure. The court order was uploaded on the court's official website on Saturday, April 04, 2026, in the late evening. The company became aware of the order on April 06, 2026, being the next working day, and made the intimation within 24 hours of receiving the order.

Key Parties Involved

Along with the company, Dr. Manika Khanna, Chairperson and Managing Director and Promoter of Gaudium IVF, is also a party to the arbitration proceedings. The opposing party, Neomile Corporate Advisory Limited, is seeking ₹29,20,50,000 (inclusive of GST) for alleged IPO advisory services.

Regulatory Compliance

The enhanced disclosure was signed by Company Secretary Naveen Kumar (Membership No: A69788) and submitted to both BSE Limited (Scrip Code – 544709) and National Stock Exchange of India Limited (Symbol – GAUDIUMIVF). The information has also been placed on the company's official website as required by regulatory guidelines.